Clinical Trials
Disclosure Policy of the Astellas Group for Information on...
The Astellas Group (*1) (hereinafter collectively “Astellas”) recognises that making clinical trial information and results more widely available to researchers, healthcare professionals, patients, and interested...
Clinical Trials
Bausch + Lomb and Nicox Announce FDA Acceptance of...
Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary, Bausch + Lomb, and Nicox S.A. announced that the U.S. Food and Drug Administration (FDA) has accepted for...
Clinical Trials
CTI BioPharma To Submit NDA For Pacritinib In Q4...
CTI BioPharma Corp. announced its plan to submit a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) following a productive pre-NDA...
Clinical Trials
Pivotal Phase 3 Studies of Bezlotoxumab, Merck’s Investigational Antitoxin...
Merck known as MSD outside the United States and Canada, today announced that the two pivotal Phase 3 clinical studies for bezlotoxumab, its investigational antitoxin...
Clinical Trials
Enox Biopharma, LTD. Announces First Enrollments of A Phase...
Enox Biopharma, Ltd., a leader in nitric oxide delivery technology for the prevention of hospital acquired infections announced today the enrollment of the first subjects...
Clinical Trials
Otsuka and GW Pharmaceutical’s multiple sclerosis drug Sativex has...
Sativex (nabiximols) is derived from cannabis and usually used to treat the symptoms of multiple sclerosis (MS). This trial was testing the drug for the...
Clinical Trials
TxCell announces start of phase IIb clinical trial with...
TxCell undertaking one of largest ever controlled studies for a personalized T cell immunotherapy product . Top line results of this study are expected...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.